Ventricular fibrillation (VF), a cause of sudden cardiac death (SCD) in the setting of acute
myocardial infarction (MI), remains a major therapeutic challenge. In humans, VF may occur …

Ventricular arrhythmia and subsequent sudden cardiac death (SCD) due to acute
myocardial infarction (AMI) is one of the most frequent causes of death in humans. Lethal …

Primary ventricular fibrillation (VF) complicating acute myocardial infarction (MI) predicts
short-term mortality. The broad category of patients with primary VF might include subgroups …

Ventricular arrhythmias occur commonly following myocardial infarction and carry important
prognostic implications. The mechanisms involved are varied and time‐dependent …

In the United States, sudden cardiac death accounts for an estimated 300,000 to 350,000
cases each year, with 80,000 presenting as the first manifestation of a preexisting …

A number of animal models have been designed in order to unravel the underlying
mechanisms of acute ischemia-induced arrhythmias and to test compounds and …

Remarkable advances have been made in the management of cardiac disease in the last 20
years, but antiarrhythmic drug strategy in the acute phase of myocardial infarction remains …

Ventricular tachyarrhythmias (VAs) commonly occur early in ischaemia, and remain a
common cause of sudden death in acute MI. The thrombolysis and primary percutaneous …

Sudden arrhythmic death is an important contributor to the mortality rate in patients with
cardiac disease, accounting for over 450 000 deaths per year in the USA alone. About 80 …

Sudden cardiac death has traditionally been defined as “the unexpected natural death from
a cardiac cause within a short period, usually 1 hour from the onset of symptoms in a person …